Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact
Aging Cell · 2026
DOI: 10.1111/acel.70766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Kassandra Vezyrgianni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Inflammation, Imperial College London, London, UK. Hauptthemen laut MEDLINE: B-Lymphocytes, Cellular Senescence, Fibroblasts, Cell Communication. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Dunhill Medical Trust, Vivensa Foundation.
Abstract (Originalsprache)
Ageing profoundly impairs vaccine efficacy, leaving older individuals highly susceptible to infectious diseases despite vaccination. Although B cells retain the intrinsic capacity to generate germinal centre (GC) responses in older people, age‐associated defects in T cells, dendritic cells and follicular dendritic cells (FDCs) limit the development of high‐affinity, class‐switched antibody responses. Here, we hypothesised that senescent fibroblasts disrupt B cell activation and expansion, thus contributing to the diminution of the humoral response in ageing. To test this hypothesis, we established an in vitro system in which human tonsil‐derived YK6 fibroblasts expressing CD40L are co‐cultured with PBMC‐derived B cells. B cell activation, proliferation, and phenotype in response to low‐ and high‐stimulation conditions was determined in co‐culture with control or bleomycin‐treated YK6 fibroblasts. Control YK6 fibroblasts promoted B‐cell activation and proliferation in both 2D and 3D cultures, whereas bleomycin‐treated fibroblasts robustly inhibited B‐cell proliferation without impairing early activation. Conditioned media from bleomycin‐treated fibroblasts partially reduced B cell proliferation, although to a lesser extent than direct co‐culture, suggesting cell–cell contact was key to inhibiting B cell proliferation. Bleomycin‐treated YK6 fibroblasts upregulated genes associated with impaired lymphocyte responses, such as PDCD1LG2 , which may impact B cell activation. Indeed, B cells co‐cultured with bleomycin‐treated fibroblasts failed to fully initiate glycolysis and were essentially unable to synthesise new protein. Together, these findings suggest that senescence‐like changes in fibroblasts could restrict B‐cell proliferative capacity, which may contribute to impaired B cell responses in ageing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Inflammation, Imperial College London, London, UK.
ORCID-Profile: Kassandra Vezyrgianni, Elizabeth MacLeod, Abigail Nutley, Alice E Denton
Förderung
- Medical Research Council
- Dunhill Medical Trust
- Vivensa Foundation
Zitieren
APA
Vezyrgianni, K., MacLeod, E., Nutley, A., Zhu, Y., & Denton, A. E. (2026). Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact. Aging Cell. https://doi.org/10.1111/acel.70766
Vancouver
Vezyrgianni K, MacLeod E, Nutley A, Zhu Y, Denton AE. Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact. Aging Cell. 2026. doi:10.1111/acel.70766
BibTeX
@article{Vezyrgianni2026,
author = {Vezyrgianni, Kassandra and MacLeod, Elizabeth and Nutley, Abigail and Zhu, Yuchen and Denton, Alice E},
title = {Senescent Fibroblasts Impair B Cell Proliferation via Cell–Cell Contact},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70766}
}
EUVIMED